Artiva Biotherapeutics Inc
ARTV
Get informed when a big investor buys or sells
+ FollowMarket Cap$534.37M
Close$
$0.64
94.5% downside
Current Fair Value
94.5% downsideOvervalued by 94.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $534.37 Million |
|---|---|
| Enterprise Value | $242.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.43 |
| Beta | 2.18 |
| Outstanding Shares | 39,413,236 |
Return
| Return on Equity | -26.14% |
|---|---|
| Return on Assets | -24.64% |
| Return on Invested Capital | -26.29% |
Valuation & Multiples
| P/E Ratio | -3.3 |
|---|---|
| PEG | -18.71 |
| Price to Sales | - |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.61 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.63
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 27, 2026
EPS Estimate
$-0.70
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 68.22%▼ 1.15% |
|---|---|
| Total Invested | $108.42M▲ 49.05% |
| Investors Holding | 40▲ 6.00% |
ESG Score
No data